Invention Grant
US09176150B2 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
有权
淀粉样蛋白β(1-42)寡聚体,其衍生物和抗体,其制备方法和用途
- Patent Title: Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
- Patent Title (中): 淀粉样蛋白β(1-42)寡聚体,其衍生物和抗体,其制备方法和用途
-
Application No.: US13195533Application Date: 2011-08-01
-
Publication No.: US09176150B2Publication Date: 2015-11-03
- Inventor: Heinz Hillen , Andreas Striebinger , Carsten Krantz , Achim Moeller , Reinhold Mueller
- Applicant: Heinz Hillen , Andreas Striebinger , Carsten Krantz , Achim Moeller , Reinhold Mueller
- Applicant Address: DE Wiesbaden
- Assignee: AbbVie Deutschland GmbH & Co. KG
- Current Assignee: AbbVie Deutschland GmbH & Co. KG
- Current Assignee Address: DE Wiesbaden
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Priority: DE10303974 20030131
- Main IPC: C07K16/18
- IPC: C07K16/18 ; G01N33/68 ; A61K38/17 ; C07K14/47 ; G01N33/53 ; A61K39/395

Abstract:
The invention relates to neuromodulatory oligomers of the amyloid-β(1-42) protein, a particular production method, by means of which the oligomer can be obtained in a reproducible manner at high yield, the use of the oligomers as diagnostic and therapeutics agents, for the generation of oligomer-specific antibodies and for the discovery of substances which can interact with the oligomers and in the formation thereof. Corresponding methods for the production of the antibodies and for discovery of the substances are also disclosed as are the antibodies themselves and the use of the antibodies or substances as diagnostic and therapeutic agents. The invention further relates to derivatives of the oligomers and oligomers based on abbreviated forms of the amyloid-β(1-42) proteins, the production and use thereof.
Public/Granted literature
Information query